http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160008523-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e29526f284c0155fd79806c9dd5a1c7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5115
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-642
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-18
filingDate 2014-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2827302a746742d45aeb98012ad7088e
publicationDate 2016-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20160008523-A
titleOfInvention Targeting corroles for tumor toxicity and mri
abstract Targeted colloidal nanoparticles; And compositions comprising acceptable excipients are disclosed herein. Targeted colloidal nanoparticles; And compositions comprising an acceptable carrier are also disclosed. A method of imaging disease in an individual is further disclosed herein, the method comprising: providing a composition comprising targeted colol nanoparticles; Administering to the subject an effective amount of a targeted colol nanoparticle; And imaging the disease in the subject. In addition, a method of treating cancer in a subject is disclosed herein, the method comprising: providing a composition comprising targeted cholol nanoparticles; And administering therapeutically effective doses of the targeted colol nanoparticles to the subject.
priorityDate 2013-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29936
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485223053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559465
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451675249

Total number of triples: 40.